The lawsuit accuses the formula maker of deceptively marketing the milks to make them seem like the next recommended step for toddlers.

Formulas marketed for toddlers are a burgeoning business, but pediatricians have long recommended against their use.

The organization that filed the proposed class action alleges marketing for the product tricks parents of young children who ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...

Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...

Abbott Laboratories (NYSE:ABT – Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock traders bought 71,494 call options on the company. This is an increase ...

This was the stock's second consecutive day of losses.

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...